GlassScriptPhysician profile
Brent V Yanke
NPI 1295959898
$4,607.71
in general payments reported to CMS, 2019-2025
21 companies · $15.79 in 2025
The $15.79 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $287 · 2021: $457 · 2022: $40.07 · 2023: $3,111 · 2024: $194 · 2025: $15.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $320.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Davinci Xi |
| Astellas Pharma US INC | $343.77 | 2019-2021 | |
| Boston Scientific Corporation | $156.01 | 2019-2024 | Rezum Generator, Greenlight Xps |
| Neotract INC. | $155.96 | 2020 | |
| Myriad Genetic Laboratories, INC. | $133.60 | 2021-2023 | Prolaris |
| Axonics, INC. | $118.93 | 2020-2024 | Bulkamid |
| Aytu Biopharma, INC. | $105.30 | 2019-2020 | |
| Teleflex LLC | $102.35 | 2021-2024 | Urolift |
| Acerus Pharmaceuticals Corporation | $98.63 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $57.91 | 2021-2023 | Trelstar |
| Coloplast Corp | $53.01 | 2019-2025 | |
| Smith+Nephew, INC. | $48.70 | 2019 | |
| Pfizer INC. | $44.43 | 2019-2021 | |
| Urogen Pharma, INC. | $42.41 | 2023-2024 | Jelmyto |
| Blue Earth Diagnostics | $29.32 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $24.95 | 2024 | |
| Myovant Sciences INC. | $22.23 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.10 | 2019 | |
| Janssen Biotech, INC. | $19.15 | 2019 | |
| 180 Medical, INC. | $17.31 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Yanke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.